Regenerative Medicine Organoid Cultures

Laboratory models simulating cellular and organ conditions for research purposes in cell biology and tissue engineering studies.

Mechanical system providing oscillatory perfusion and nutrient delivery to organ chip cultures. Supports extended culture periods and metabolic assessment in pharmaceutical testing.

Technology platform for developing and testing microphysiological systems that simulate human organ and tissue behavior in vitro. Enables preclinical drug testing, toxicology assessment, and disease modeling with improved physiological relevance compared to conventional cell cultures. Integrates microfluidics, tissue engineering, and analytical capabilities for pharmaceutical and biomedical research applications.

Specialized microfluidic organ-on-chip platforms for in vitro tissue modeling and drug testing in biomedical research.

Advanced microfluidic organ-on-a-chip devices that model human organ functions for drug testing and disease research. These systems provide realistic biological microenvironments for preclinical evaluation of therapeutics.

Microfluidic platforms designed for high-throughput organoid, spheroid and organ-on-chip culturing and analysis. These systems enable controlled environments for advanced biological research and drug development.

Cancer organoid growth kit utilizing organ-on-chip technology to create high-fidelity human tissue models for drug efficacy evaluation and clinical treatment planning. Enables personalized medicine through rapid assessment of therapeutic response and toxicity in cancer research and oncology applications.

Microfluidic platforms specifically designed for high-throughput organoid, spheroid, and organ-on-chip culturing and analysis. These systems provide controlled biological environments for advanced research and drug development applications.

A microfluidic-based system for creating and studying organ-like tissue structures in vitro. It enables advanced cell culture, perfusion, and multi-reagent delivery for studying organ function and drug responses.

A three-dimensional in vitro cell culture system that establishes patient-derived tumor organoid models highly similar to patient tumor characteristics. The tumor organoids maintain high consistency with patient tumor pathological, molecular, and genetic features while enabling personalized drug sensitivity assessment, with reported accuracy up to 80%.

Organ-on-chip microfluidic devices that model human tissue and organ function in vitro for drug testing, toxicology, and disease research. These bioengineered chips integrate multiple cell types in physiologically relevant configurations, enabling predictive evaluation of therapeutic efficacy and safety. Applications include pharmaceutical development, personalized medicine, and reduction of animal testing in preclinical studies.

Microfluidic device platform designed for organ tissue modeling and in vitro biological simulation. Incorporates low-autofluorescence materials suitable for continuous monitoring and optical imaging of cellular systems.